These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36472717)

  • 1. TIVAP-related infection due to Gram-negative aerobic bacilli: should TIVAP stay or should it go?
    Rolland S; Kassis-Chikhani N; Auclin E; Bensaid S; Bidaud AL; Gerlinger MP; Blez D; Mainardi JL; Lebeaux D; Dubert M
    Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):161-168. PubMed ID: 36472717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of totally implantable venous-access port-related infections.
    Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
    Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature.
    Lebeaux D; Larroque B; Gellen-Dautremer J; Leflon-Guibout V; Dreyer C; Bialek S; Froissart A; Hentic O; Tessier C; Ruimy R; Pelletier AL; Crestani B; Fournier M; Papo T; Barry B; Zarrouk V; Fantin B
    Medicine (Baltimore); 2012 Nov; 91(6):309-318. PubMed ID: 23117849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
    Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
    J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study.
    Bailleul A; Fulgencio JP; Vimont S; Mordelet C; Ray B; Lassel L; Lapidus N; Quesnel C; Garnier M
    Infect Dis Now; 2023 Oct; 53(8):104766. PubMed ID: 37543258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
    Lafaurie M; Montlahuc C; Kerneis S; de Lastours V; Abgrall S; Manceron V; Couzigou C; Chabrol A; de Raigniac A; Lescure X; Longuet P; Lesprit P; Vanjak D; Lepeule R;
    J Antimicrob Chemother; 2023 May; 78(5):1253-1258. PubMed ID: 37014800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
    Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
    Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.
    Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I
    Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
    Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
    Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factor for infection of totally implantable venous access port.
    Chang TC; Yen MH; Kiu KT
    Langenbecks Arch Surg; 2022 Feb; 407(1):343-351. PubMed ID: 34550464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of infection of totally implantable venous access port: A retrospective study.
    Guan X; Yan H; Zhang J; Li Y; Zhou Y
    J Vasc Access; 2023 Nov; 24(6):1340-1348. PubMed ID: 35389296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of totally implanted venous access ports for suspected infection in the intensive care unit: a multicenter observational study.
    Lecronier M; Valade S; Bigé N; de Prost N; Roux D; Lebeaux D; Maury E; Azoulay E; Demoule A; Dres M;
    Ann Intensive Care; 2018 Mar; 8(1):41. PubMed ID: 29594891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiological characteristics of patients with severe burns caused by blast and application of meta- genomics next-generation sequencing in the detection of pathogenic microorganisms].
    Luo RB; Huang M; Hu H; Zhang R; Han CM
    Zhonghua Shao Shang Za Zhi; 2021 Oct; 37(10):946-952. PubMed ID: 34689464
    [No Abstract]   [Full Text] [Related]  

  • 16. Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli.
    Hsu JF; Chang HL; Tsai MJ; Tsai YM; Lee YL; Chen PH; Fan WC; Su YC; Yang CJ
    World J Surg Oncol; 2015 Sep; 13():288. PubMed ID: 26420628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.
    Yu XY; Xu JL; Li D; Jiang ZF
    Medicine (Baltimore); 2018 Sep; 97(38):e12427. PubMed ID: 30235721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center.
    Ji L; Yang J; Miao J; Shao Q; Cao Y; Li H
    Cell Biochem Biophys; 2015 May; 72(1):235-40. PubMed ID: 25542370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Lock Therapy in the Era of Gram-Negative Resistance.
    Soman R; Gupta N; Suthar M; Kothari J; Almeida A; Shetty A; Rodrigues C
    J Assoc Physicians India; 2016 Feb; 64(2):32-37. PubMed ID: 27730778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Safety, and Cost-Effectiveness of Intracavitary Electrocardiography-Guided Catheter Tip Placement for Totally Implantable Venous Access Port.
    Liu Z; Zheng X; Zhen Y; Liu X; Lin F; Ye Z; Liu P
    Ann Vasc Surg; 2022 Jul; 83():168-175. PubMed ID: 34936891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.